IR Information
FY2024 4Q Financial Results Presentation Summary of Q&A Session
Our Company‘s Position on the ISS Report
May 30, 2025 Management Presentation Materials
Notice of Convocation of the 166th Ordinary General Meeting of Shareholders Other Matters Subject to the Electronic Provision
Notice of Convocation of the 166th Ordinary General Meeting of Shareholders
News
New Building for the Manufacture of Diagnostic Reagents, Including Antigen Detection Kits, Is Now in Operation
Facility reinforcement projected for production of ALSINK, a high-reliability heat-dissipating base plate – Strengthening supply system for growing uses of this material in power modules –
This website uses cookies to ensure that you use this website comfortably. If you continue to browse this website, you will agree to the use of our cookies.